These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 216860)

  • 1. [Oral contraceptives and HDL cholesterol].
    Frankman O; Marsk L; Rössner S
    Lakartidningen; 1979 Jan; 76(1-2):15-6. PubMed ID: 216860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of long-term use of composite steroid contraceptives on serum lipids in women].
    Li ZX
    Zhonghua Fu Chan Ke Za Zhi; 1983 Apr; 18(2):98-100. PubMed ID: 6628082
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
    Nash AL; Cornish EJ; Hain R
    Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in serum lipoproteins in women treated with combined oral contraceptives].
    Bellod P; Serrano C; Díaz A; Tejero T; Nuño J; de Oya M
    Rev Clin Esp; 1983 Sep; 170(6):275-8. PubMed ID: 6658069
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of a combined oral contraceptive pill in black Zimbabwean women.
    Kasule J; Mbizvo M; Makuyana D; Masona D
    Cent Afr J Med; 1991 Dec; 37(12):403-9. PubMed ID: 1806254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraception in diabetic women. A cross-over study on serum and high density lipoprotein (HDL) lipids and diabetes control during progestogen and combined estrogen/progestogen contraception.
    Rådberg T; Gustafson A; Skryten A; Karlsson K
    Horm Metab Res; 1982 Feb; 14(2):61-5. PubMed ID: 7040192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
    Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.
    Gaspard U; Endrikat J; Desager JP; Buicu C; Gerlinger C; Heithecker R
    Contraception; 2004 Apr; 69(4):271-8. PubMed ID: 15033400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential changes in plasma high-density lipoprotein-cholesterol levels in obese men and women during weight reduction.
    Brownell KD; Stunkard AJ
    Arch Intern Med; 1981 Aug; 141(9):1142-6. PubMed ID: 7259372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of two monophasic oral contraceptives containing gestodene or desogestrel on serum lipoprotein lipid levels.
    Leuven JA; de Pagter HA; Dersjant-Roorda MA; Helmerhorst FA; Roelofsen J
    Int J Fertil; 1989 Sep; 34 Suppl():55-60. PubMed ID: 2576261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized prospective study of the metabolic effects of four low-estrogen oral contraceptives.
    Briggs MH
    J Reprod Med; 1983 Jan; 28(1 Suppl):92-9. PubMed ID: 6403706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of gemfibrozil therapy for raising high density lipoprotein levels.
    Weis S; Kudchodkar BJ; Clearfield MB; Lacko AG
    Artery; 1992; 19(6):353-66. PubMed ID: 1471924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Do's and don'ts for a woman who has an abnormal lipid pattern and is taking oral contraceptives].
    Boyet F
    Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1076-7. PubMed ID: 12266510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins.
    Arora S; Arora RC; Garg RK; Agarwal N; Nautiyal A
    Indian J Physiol Pharmacol; 1988; 32(1):67-71. PubMed ID: 3169963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein-lipid composition in premenopausal women.
    Després JP; Moorjani S; Tremblay A; Ferland M; Lupien PJ; Nadeau A; Bouchard C
    Clin Invest Med; 1989 Dec; 12(6):374-80. PubMed ID: 2612090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Women and ischemic cardiopathy].
    Assmann G; Davignon J; Fernández Cruz A; Gotto AM; Jacotot B; Lewis B; Paoletti R
    Rev Clin Esp; 1989 Oct; 185(6):308-15. PubMed ID: 2695994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile.
    Creasy GW; Fisher AC; Hall N; Shangold GA
    J Reprod Med; 2003 Mar; 48(3):179-86. PubMed ID: 12698776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cigarettes, contraceptive drugs and lipidogenesis in the female].
    Lederer J
    Sem Hop; 1983 Dec; 59(49):3413-6. PubMed ID: 6320418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
    Winkler UH; Sudik R
    Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.